# Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

> **NCT00715351** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 342 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin NPH

## Key facts

- **NCT ID:** NCT00715351
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715351, "Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00715351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*